The CBD nutraceuticals market size valued at USD 3.8 Billion in 2022 and is anticipated to reach USD 16.9 Billion by 2032 at a CAGR of 16.3%.
Get Free Sample Report: https://datahorizzonresearch.c....om/request-sample-pd
Cannabidiol (CBD), derived from the cannabis sativa plant, serves as an active ingredient utilized for various medicinal purposes. Its applications extend to treating conditions such as epilepsy, pain management, dystonia, Parkinson's disease, Crohn's disease, and more. Unlike Tetrahydrocannabinol (THC), CBD lacks psychoactive properties, making it a sought-after option for therapeutic use. Its numerous health benefits drive its integration into nutraceutical products, consequently fueling market expansion.
Like
Comment
Share
